Seres Therapeutics (MCRB) PT Lowered to $15 at Canaccord Genuity; Maintains Buy
Tweet Send to a Friend
Canaccord Genuity analyst John Newman lowered ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
